Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR-ABL kinase domain mutations affect patient survival?? First multicenter Argentinean study.

Autor: Bengió, Raquel M.¹ (AUTHOR) mutaciones2@yahoo.com.ar, Riva, Maria E.² (AUTHOR), Moiraghi, Beatriz³ (AUTHOR), Lanari, Emilio⁴ (AUTHOR), Milone, Jorge⁵ (AUTHOR), Ventriglia, Veronica⁶ (AUTHOR), Bullorsky, Eduardo⁷ (AUTHOR), Tezanos pinto, Miguel de¹ (AUTHOR), Murro, Hector⁸ (AUTHOR), Bianchini, Michele⁹ (AUTHOR), Larripa, Irene⁹ (AUTHOR)

Publikováno v: Leukemia & Lymphoma. Sep2011, Vol. 52 Issue 9, p1720-1726. 7p. 3 Charts, 3 Graphs.

Cytogenetic Features and Prognosis of 943 South American Patients with De Novo Myelodysplastic Syndromes: A Multicenter Study

Autor: Belli, Carolina ^*, Feitosa Pinheiro, Ronald ^*, Magalhaes, Silvia M.M. ^*, Gonzalez, Jacqueline ^*, Iastrebner, Marcelo, Prates, Maria Virginia ^*, Benasayag, Silvia ^*, Bestach, Yesica ^*, Cordeiro, Juliana ^*, Cavalcante de Andrade Silva, Marcela ^*, da Silva Tanizawa, Roberta ^*, Bengió, Raquel M ^*, Lang, Cecilia ^*, Nucifora, Elsa ^*, Larripa, Irene B ^*, Velloso, Elvira RP

Publikováno v: In Blood 6 December 2014 124(21):5618-5618

Ruxolitinib In Myelofibrosis (MF) Patients Through Compassionate Use Program (CUP). Argentinian Experience

Autor: Alzate, Mauricio A ^*, Mela Osorio, María J ^*, Barreyro, Paula ^*, Enrico, Alicia Inés ^*, García de Labanca, Ana ^*, Negri, Pedro ^*, Varela, Ana Inés ^*, Vitriu, Adriana ^*, Bär, Daniel ^*, Benzadón, Ricardo ^*, Burgos, Rubén ^*, Celebrín, Lucía ^*, Ceresetto, Jose Manuel ^*, Corzo, Ariel ^*, Fernández, Isolda ^*, Flores, María Gabriela ^*, Galeazzi, Ana Victoria ^*, Lanari Zubiaur, Emilio A, Molinas, Felisa C., Orlando, Sergio M ^*, Pavlovsky, Miguel A, Remaggi, Guillermina ^*, Riveros, Dardo Alberto ^*, Rudoy, Silvia ^*, Taborda, Gustavo ^*, Sánchez Avalos, Julio César, Sackmann, Federico ^*, Bengió, Raquel M ^*

Publikováno v: In Blood 15 November 2013 122(21):5247-5247

BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival.

Autor: Pagnano KB; a 1 Hemocentro-UNICAMP , University of Campinas, Campinas , São Paulo, Brazil., Bendit I; b 2 Laboratório de Biologia Tumoral , University of São Paulo, São Paulo , São Paulo, Brazil., Boquimpani C; c 3 Hemorio, Rio de Janeiro , Rio de Janeiro, Brazil., De Souza CA; a 1 Hemocentro-UNICAMP , University of Campinas, Campinas , São Paulo, Brazil., Miranda EC; a 1 Hemocentro-UNICAMP , University of Campinas, Campinas , São Paulo, Brazil., Zalcberg I; d 4 Instituto Nacional do Câncer, Rio de Janeiro , Rio de Janeiro, Brazil., Larripa I; e 5 Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina de Buenos Aires , Buenos Aires, Argentina., Nardinelli L; b 2 Laboratório de Biologia Tumoral , University of São Paulo, São Paulo , São Paulo, Brazil., Silveira RA; a 1 Hemocentro-UNICAMP , University of Campinas, Campinas , São Paulo, Brazil., Fogliatto L; f 6 Hospital das Clínicas de Porto Alegre, Porto Alegre , Rio Grande do Sul, Brazil., Spector N; g 7 Federal University of Rio de Janeiro , Rio de Janeiro , Rio de Janeiro, Brazil., Funke V; h 8 Universidade Federal do Paraná , Curitiba, Paraná, Brazil., Pasquini R; h 8 Universidade Federal do Paraná , Curitiba, Paraná, Brazil., Hungria V; i 9 Santa Casa de São Paulo, São Paulo , São Paulo, Brazil., Chiattone CS; i 9 Santa Casa de São Paulo, São Paulo , São Paulo, Brazil., Clementino N; j 10 Universidade Federal de Minas Gerais , Belo Horizonte , Minas Gerais, Brazil., Conchon M; k 11 Hospital Santa Marcelina , São Paulo, São Paulo, Brazil., Moiraghi EB; l 12 Hospital Ramos Mejía , Buenos Aires, Argentina., Lopez JL; m 13 Banco Municipal de Sangre del DC , Caracas, Venezuela., Pavlovsky C; n 14 FUNDALEU , Buenos Aires, Argentina., Pavlovsky MA; n 14 FUNDALEU , Buenos Aires, Argentina., Cervera EE; o 15 INCAN , Mexico, D.F., Mexico., Meillon LA; p 16 Centro Médico Nacional Siglo XXI , Mexico, D.F., Mexico., Simões B; q 17 University of São Paulo , Ribeirão Preto, São Paulo, Brazil., Hamerschlak N; r 18 Hospital Israelita Albert Einstein , São Paulo, São Paulo, Brazil., Bozzano AH; s 19 Hospital Maciel , Montevideo, Uruguay., Mayta E; t 20 Instituto Oncologico Nacional , Panamá, Panama., Cortes J; u 21 MD Anderson Cancer Center , Houston, Texas, USA., Bengió RM; e 5 Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina de Buenos Aires , Buenos Aires, Argentina.

Publikováno v: Cancer investigation [Cancer Invest] 2015; Vol. 33 (9), pp. 451-8. Date of Electronic Publication: 2015 Aug 17.